BACTERIAL MODULATION OF LUNG INFLAMMATORY RESPONSE
Project Number5R01HL069763-03
Former Number1R01AI044843-01A2
Contact PI/Project LeaderRUSSO, THOMAS A
Awardee OrganizationSTATE UNIVERSITY OF NEW YORK AT BUFFALO
Description
Abstract Text
DESCRIPTION (Unedited Applicant's Abstract): Gram-negative bacilli (GNB) are
pathogens that are capable of causing severe, life-threatening pneumonia. More
than 60 percent of nosocomial pneumonias are caused by GNB and associated
mortality rates are often >50 percent. Over the last 10-15 years, there has
been little improvement in outcome from this infection. As a result, this
syndrome continues to cause significant morbidity and mortality and strongly
contributes to the economic burden of our national health care system.
The successful use of immune intervention in the treatment or modulation of
infections has marked the beginning of a new era in the management of
infectious diseases. There exists a delicate balance between an efficacious and
injurious host defense response. An understanding of the host response in GNB
pneumonia and how bacterial components affect this response will, in turn, lead
to the development of rapid diagnostic tests that will enable the clinician to
effectively utilize a variety of biologic modulators. It is also necessary to
understand the relative role of bacterial components versus host factors in
mediating damage to the lungs prior to therapeutic manipulations on which
little is known. This information will enable us to appreciate the relative
risk benefit ratio of altering the host response. Further, a more precise
clarification of which host components are damaged is also needed. This
knowledge may identify independent therapeutic interventions.
Their global hypothesis is that surface components of GNB and/or secreted
proteins differentially alter host antibacterial defenses and directly, and/or
indirectly (by inflammatory mechanisms) promote lung injury. Preliminary data
supports this hypothesis. These responses will have significant implications
when attempting therapeutic immune interventions. The goals of this proposal
are to determine the mechanisms by which the bacterial capsule and 0-specific
antigen modulate neutrophil recruitment into the lungs in a diametrical manner
and extend our evaluations on the relative roles of bacterial factors (e.g.
hemolysin) and bacterially induced host response elements in directly mediating
the pathogenesis of lung injury.
No Sub Projects information available for 5R01HL069763-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL069763-03
Patents
No Patents information available for 5R01HL069763-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL069763-03
Clinical Studies
No Clinical Studies information available for 5R01HL069763-03
News and More
Related News Releases
No news release information available for 5R01HL069763-03
History
No Historical information available for 5R01HL069763-03
Similar Projects
No Similar Projects information available for 5R01HL069763-03